Table 3.
Quality Assessment | Summary of Findings | |||||||
---|---|---|---|---|---|---|---|---|
Directness | No of events | |||||||
No of studies | Design | Limitations | Consistency | Generalizability to population of interest | Generalizability to intervention of interest | Intervention | Control | RR or SMD (95% CI) |
Respiratory infections: Moderate outcome-specific quality | ||||||||
3 studies [20,22,26] | RCT | Random effect model was used because of heterogeneity | One study suggest benefit | 375 | 448 | RR 0.67 (0.49, 0.91) | ||
Diarrhea/vomiting: Moderate outcome-specific quality | ||||||||
3 studies [20,22,26] | RCT | Random effect model was used because of heterogeneity | None of the study suggest benefit | 424 | 488 | RR 0.75 (0.42, 1.35) | ||
Fever: low outcome-specific quality | ||||||||
2 studies [17,22] | RCT | Random effect model was used because of heterogeneity | None of the study suggest benefit | 195 | 187 | RR 0.89 ( 0.41, 1.90) |